Dr. Reddy’s unveils cancer drug in U.S.
December 28th, 2017
Dr. Reddy’s Laboratories has introduced Melphalan Hydrochloride for injection, a therapeutic equivalent generic version of Alkeran for injection, in the U.S. market. Melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. It has been approved by the U.S. Food and Drug Administration.